Steamboat Capital Partners’s United Therapeutics UTHR Stock Holding History

Steamboat Capital Partners’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,993	Closed	-$1.79M	–	61
2024 Q3	$1.79M	Buy	+4,993	New	+$1.69M	0.56%	36
2022 Q2	–	Sell	-51,717	Closed	-$9.28M	–	47
2022 Q1	$9.28M	Sell	51,717 -156	-0.3%	-$29.7K	2.74%	18
2021 Q4	$11.2M	Sell	51,873 -5,303	-9%	-$1.04M	3.43%	11
2021 Q3	$10.6M	Sell	57,176 -284	-0.5%	-$55.9K	2.45%	19
2021 Q2	$10.3M	Sell	57,460 -18,395	-24%	-$3.5M	2.66%	17
2021 Q1	$12.7M	Buy	+75,855	New	+$12.6M	3.74%	8

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Steamboat Capital Partners's UTHR Position: Q4 2024 in Review

Steamboat Capital Partners sold out of United Therapeutics (UTHR) in Q4 2024, closing a stake of 4,993 shares — an estimated $1.79M sold.

Steamboat Capital Partners first reported a position in UTHR in Q1 2021 and held it in 6 quarters. The position peaked at $12.7M in Q1 2021. 673 funds tracked by Wall St. Rank hold UTHR as of Q4 2024.

Steamboat Capital Partners reported no remaining United Therapeutics position as of Q4 2024 after selling out during the quarter.
Steamboat Capital Partners sold 4,993 United Therapeutics shares in Q4 2024, an estimated $1.79M.
Steamboat Capital Partners first reported a position in United Therapeutics in Q1 2021 and held it in 6 quarters.
Steamboat Capital Partners's United Therapeutics position peaked at $12.7M in Q1 2021.
673 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2024.

Based on Steamboat Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.